{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antiviral agents", "dehydrojuncusol", "hepatitis C virus", "natural antimicrobial products", "phenanthrene", "viral replication"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30842319", "DateCompleted": {"Year": "2020", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "01"}], "Language": ["eng"], "ELocationID": ["e02009-18", "10.1128/JVI.02009-18"], "Journal": {"ISSN": "1098-5514", "JournalIssue": {"Volume": "93", "Issue": "10", "PubDate": {"Year": "2019", "Month": "May", "Day": "15"}}, "Title": "Journal of virology", "ISOAbbreviation": "J Virol"}, "ArticleTitle": "Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from <i>Juncus maritimus</i>, Is a New Inhibitor of Hepatitis C Virus RNA Replication.", "Abstract": {"AbstractText": ["Recent emergence of direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) proteins has considerably enhanced the success of antiviral therapy. However, the appearance of DAA-resistant-associated variants is a cause of treatment failure, and the high cost of DAAs renders the therapy not accessible in countries with inadequate medical infrastructures. Therefore, the search for new inhibitors with a lower cost of production should be pursued. In this context, the crude extract of <i>Juncus maritimus</i> Lam. was shown to exhibit high antiviral activity against HCV in cell culture. Bio-guided fractionation allowed the isolation and identification of the active compound, dehydrojuncusol. A time-of-addition assay showed that dehydrojuncusol significantly inhibited HCV infection when added after virus inoculation of HCV genotype 2a (50% effective concentration [EC<sub>50</sub>] = 1.35\u2009\u00b5M). This antiviral activity was confirmed with an HCV subgenomic replicon, and no effect on HCV pseudoparticle entry was observed. Antiviral activity of dehydrojuncusol was also demonstrated in primary human hepatocytes. No <i>in vitro</i> toxicity was observed at active concentrations. Dehydrojuncusol is also efficient on HCV genotype 3a and can be used in combination with sofosbuvir. Interestingly, dehydrojuncusol was able to inhibit RNA replication of two frequent daclatasvir-resistant mutants (L31M or Y93H in NS5A). Finally, mutants resistant to dehydrojuncusol were obtained and showed that the HCV NS5A protein is the target of the molecule. In conclusion, dehydrojuncusol, a natural compound extracted from <i>J. maritimus</i>, inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.<b>IMPORTANCE</b> Tens of millions of people are infected with hepatitis C virus (HCV) worldwide. Recently marketed direct-acting antivirals (DAAs) targeting HCV proteins have enhanced the efficacy of treatment. However, due to its high cost, this new therapy is not accessible to the vast majority of infected patients. Furthermore, treatment failures have also been reported due to the appearance of viral resistance. Here, we report on the identification of a new HCV inhibitor, dehydrojuncusol, that targets HCV NS5A and is able to inhibit RNA replication of replicons harboring resistance mutations to anti-NS5A DAAs used in current therapy. Dehydrojuncusol is a natural compound isolated from <i>Juncus maritimus</i>, a halophilic plant species that is very common in coastlines worldwide. This molecule might serve as a lead for the development of a new therapy that is more accessible to hepatitis C patients in the future."], "CopyrightInformation": "Copyright \u00a9 2019 American Society for Microbiology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Sahuc", "ForeName": "Marie-Emmanuelle", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Universit\u00e9 du Littoral C\u00f4te d'Opale, EA 7394, Lille, France."}, {"Identifier": [], "Affiliation": "Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-C\u00e9dria (CBBC), Hammam-lif, Tunisia."}], "LastName": "Sahli", "ForeName": "Ramla", "Initials": "R"}, {"Identifier": ["0000-0002-8618-5530"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Universit\u00e9 du Littoral C\u00f4te d'Opale, EA 7394, Lille, France."}], "LastName": "Rivi\u00e8re", "ForeName": "C\u00e9line", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Paris Descartes, EA4474 \"Hepatitis C Virology,\" Paris, France."}], "LastName": "P\u00e8ne", "ForeName": "V\u00e9ronique", "Initials": "V"}, {"Identifier": ["0000-0003-3308-811X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Lavie", "ForeName": "Muriel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Vandeputte", "ForeName": "Alexandre", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Brodin", "ForeName": "Priscille", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University Paris Descartes, EA4474 \"Hepatitis C Virology,\" Paris, France."}], "LastName": "Rosenberg", "ForeName": "Arielle R", "Initials": "AR"}, {"Identifier": ["0000-0003-1626-7693"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Dubuisson", "ForeName": "Jean", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Aromatic and Medicinal Plants, Biotechnology Centre of Borj-C\u00e9dria (CBBC), Hammam-lif, Tunisia."}], "LastName": "Ksouri", "ForeName": "Riadh", "Initials": "R"}, {"Identifier": ["0000-0003-0788-9271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France."}], "LastName": "Rouill\u00e9", "ForeName": "Yves", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut Charles Viollette (ICV), University of Lille, INRA, ISA, University Artois, Universit\u00e9 du Littoral C\u00f4te d'Opale, EA 7394, Lille, France."}], "LastName": "Sahpaz", "ForeName": "Sevser", "Initials": "S"}, {"Identifier": ["0000-0002-9667-133X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Infection and Immunity of Lille (CIIL), University of Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019, UMR 8204, Lille, France karin.seron@ibl.cnrs.fr."}], "LastName": "S\u00e9ron", "ForeName": "Karin", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Virol", "NlmUniqueID": "0113724", "ISSNLinking": "0022-538X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthrenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenethylamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "1126-71-2", "NameOfSubstance": "N,N-dimethylphenylethylamine"}, {"RegistryNumber": "448J8E5BST", "NameOfSubstance": "phenanthrene"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["genetics"], "DescriptorName": "Drug Resistance, Viral"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Hepacivirus"}, {"QualifierName": ["genetics", "virology"], "DescriptorName": "Hepatitis C"}, {"QualifierName": ["virology"], "DescriptorName": "Hepatitis C, Chronic"}, {"QualifierName": ["virology"], "DescriptorName": "Hepatocytes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Phenanthrenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenethylamines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Replicon"}, {"QualifierName": [], "DescriptorName": "Rhizome"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Levrero M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834\u20133847. doi:10.1038/sj.onc.1209562.", "ArticleIdList": ["10.1038/sj.onc.1209562", "16799625"]}, {"Citation": "Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. 2015. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61:77\u201387. doi:10.1002/hep.27259.", "ArticleIdList": ["10.1002/hep.27259", "PMC4303918", "25069599"]}, {"Citation": "Polaris Observatory HCV Collaborators. 2017. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2:161\u2013176. doi:10.1016/S2468-1253(16)30181-9.", "ArticleIdList": ["10.1016/S2468-1253(16)30181-9", "28404132"]}, {"Citation": "Tarr AW, Khera T, Hueging K, Sheldon J, Steinmann E, Pietschmann T, Brown RJP. 2015. Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: structural and functional consequences and the implications for vaccine design. Viruses 7:3995\u20134046. doi:10.3390/v7072809.", "ArticleIdList": ["10.3390/v7072809", "PMC4517138", "26193307"]}, {"Citation": "Pawlotsky J. 2014. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology 146:1176\u20131192. doi:10.1053/j.gastro.2014.03.003.", "ArticleIdList": ["10.1053/j.gastro.2014.03.003", "24631495"]}, {"Citation": "Graham CS, Swan T. 2015. A path to eradication of hepatitis C in low- and middle-income countries. Antiviral Res 119:89\u201396. doi:10.1016/j.antiviral.2015.01.004.", "ArticleIdList": ["10.1016/j.antiviral.2015.01.004", "25615583"]}, {"Citation": "Pawlotsky J-M. 2016. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology 151:70\u201386. doi:10.1053/j.gastro.2016.04.003.", "ArticleIdList": ["10.1053/j.gastro.2016.04.003", "27080301"]}, {"Citation": "Lindenbach BD, Thiel H-J, Rice CM. 2007. Flaviviridae: the viruses and their replication, p 1101\u20131152. In Knipe DM, Howley PM (ed), Fields virology, 5th ed Lippincott, William & Wilkins, Philadelphia, PA."}, {"Citation": "Egger D, W\u00f6lk B, Gosert R, Bianchi L, Blum HE, Moradpour D, Bienz K. 2002. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76:5974\u20135984. doi:10.1128/JVI.76.12.5974-5984.2002.", "ArticleIdList": ["10.1128/JVI.76.12.5974-5984.2002", "PMC136238", "12021330"]}, {"Citation": "Sarrazin C. 2016. The importance of resistance to direct antiviral drugs in HCV infection in clinical practice. J Hepatol 64:486\u2013504. doi:10.1016/j.jhep.2015.09.011.", "ArticleIdList": ["10.1016/j.jhep.2015.09.011", "26409317"]}, {"Citation": "Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629\u2013661. doi:10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Abreu AC, McBain AJ, Sim\u00f5es M. 2012. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep 29:1007\u20131021. doi:10.1039/c2np20035j.", "ArticleIdList": ["10.1039/c2np20035j", "22786554"]}, {"Citation": "Gibbons S. 2004. Anti-staphylococcal plant natural products. Nat Prod Rep 21:263\u2013277. doi:10.1039/b212695h.", "ArticleIdList": ["10.1039/b212695h", "15042149"]}, {"Citation": "Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311\u2013335. doi:10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Calland N, Dubuisson J, Rouill\u00e9 Y, S\u00e9ron K. 2012. Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 4:2197\u20132217. doi:10.3390/v4102197.", "ArticleIdList": ["10.3390/v4102197", "PMC3497048", "23202460"]}, {"Citation": "Polyak SJ, Oberlies NH, P\u00e9cheur E-I, Dahari H, Ferenci P, Pawlotsky J-M. 2013. Silymarin for HCV infection. Antivir Ther 18:141\u2013147. doi:10.3851/IMP2402.", "ArticleIdList": ["10.3851/IMP2402", "PMC4076489", "23011959"]}, {"Citation": "Ksouri R, Ksouri WM, Jallali I, Debez A, Magn\u00e9 C, Hiroko I, Abdelly C. 2012. Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications. Crit Rev Biotechnol 32:289\u2013326. doi:10.3109/07388551.2011.630647.", "ArticleIdList": ["10.3109/07388551.2011.630647", "22129270"]}, {"Citation": "Hajarizadeh B, Grebely J, Dore GJ. 2013. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 10:553\u2013562. doi:10.1038/nrgastro.2013.107.", "ArticleIdList": ["10.1038/nrgastro.2013.107", "23817321"]}, {"Citation": "Sahli R, Rivi\u00e8re C, Neut C, Bero J, Sahuc M-E, Smaoui A, Beaufay C, Roumy V, Hennebelle T, Rouill\u00e9 Y, Quetin-Leclercq J, S\u00e9ron K, Ksouri R, Sahpaz S. 2017. An ecological approach to discover new bioactive extracts and products: the case of extremophile plants. J Pharm Pharmacol 69:1041\u20131055. doi:10.1111/jphp.12728.", "ArticleIdList": ["10.1111/jphp.12728", "28444868"]}, {"Citation": "Sahuc M-E, Sahli R, Rivi\u00e8re C, P\u00e8ne V, Lavie M, Vandeputte A, Brodin P, Rosenberg A, Dubuisson JD, Ksouri R, Rouill\u00e9 Y, Sahpaz S, S\u00e9ron K. 2018. Dehydrojuncusol, a natural phenanthrene compound extracted from Juncus maritimus is a new inhibitor of hepatitis C virus replication. bioRxiv 10.1101/469361.", "ArticleIdList": ["10.1101/469361", "PMC6498043", "30842319"]}, {"Citation": "Sarkar H, Zerezghi M, Bhattacharyya J. 1988. Dehydrojuncusol, a constituent of the roots of Juncus roemerianus. Phytochemistry 27:3006\u20133008. doi:10.1016/0031-9422(88)80714-3.", "ArticleIdList": ["10.1016/0031-9422(88)80714-3"]}, {"Citation": "Ciesek S, Von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, Manns MP, Ott M, Wedemeyer H, Meuleman P, Pietschmann T, Steinmann E. 2011. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 54:1947\u20131955. doi:10.1002/hep.24610.", "ArticleIdList": ["10.1002/hep.24610", "21837753"]}, {"Citation": "Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouill\u00e9 Y, S\u00e9ron K. 2012. (\u2013)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55:720\u2013729. doi:10.1002/hep.24803.", "ArticleIdList": ["10.1002/hep.24803", "22105803"]}, {"Citation": "Calland N, Sahuc M-E, Belouzard S, P\u00e8ne V, Bonnafous P, Mesalam AA, Deloison G, Descamps V, Sahpaz S, Wychowski C, Lambert O, Brodin P, Duverlie G, Meuleman P, Rosenberg AR, Dubuisson J, Rouill\u00e9 Y, S\u00e9ron K. 2015. Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J Virol 89:10053\u201310063. doi:10.1128/JVI.01473-15.", "ArticleIdList": ["10.1128/JVI.01473-15", "PMC4577911", "26202241"]}, {"Citation": "Fridell RA, Qiu D, Valera L, Wang C, Rose RE, Gao M. 2011. Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052. J Virol 85:7312\u20137320. doi:10.1128/JVI.00253-11.", "ArticleIdList": ["10.1128/JVI.00253-11", "PMC3126594", "21593143"]}, {"Citation": "Krishnan P, Beyer J, Mistry N, Koev G, Reisch T, DeGoey D, Kati W, Campbell A, Williams L, Xie W, Setze C, Molla A, Collins C, Pilot-Matias T. 2015. In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A. Antimicrob Agents Chemother 59:979\u2013987. doi:10.1128/AAC.04226-14.", "ArticleIdList": ["10.1128/AAC.04226-14", "PMC4335823", "25451055"]}, {"Citation": "Lam AM, Murakami E, Espiritu C, Steuer HMM, Niu C, Keilman M, Bao H, Zennou V, Bourne N, Julander JG, Morrey JD, Smee DF, Frick DN, Heck JA, Wang P, Nagarathnam D, Ross BS, Sofia MJ, Otto MJ, Furman PA. 2010. PSI-7851, a pronucleotide of beta-D-2\u2019-deoxy-2\u2019-fluoro-2\u2019-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob Agents Chemother 54:3187\u20133196. doi:10.1128/AAC.00399-10.", "ArticleIdList": ["10.1128/AAC.00399-10", "PMC2916354", "20516278"]}, {"Citation": "Ascher DB, Wielens J, Nero TL, Doughty L, Morton CJ, Parker MW. 2014. Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA. Sci Rep 4:4765. doi:10.1038/srep04765.", "ArticleIdList": ["10.1038/srep04765", "PMC3996483", "24755925"]}, {"Citation": "Lontok E, Harrington P, Howe A, Kieffer T, Lennerstrand J, Lenz O, McPhee F, Mo H, Parkin N, Pilot-Matias T, Miller V. 2015. Hepatitis C virus drug resistance-associated substitutions: state of the art summary. Hepatology 62:1623\u20131632. doi:10.1002/hep.27934.", "ArticleIdList": ["10.1002/hep.27934", "26095927"]}, {"Citation": "Fridell RA, Wang C, Sun J-H, O'Boyle DR, Nower P, Valera L, Qiu D, Roberts S, Huang X, Kienzle B, Bifano M, Nettles RE, Gao M. 2011. Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations. Hepatology 54:1924\u20131935. doi:10.1002/hep.24594.", "ArticleIdList": ["10.1002/hep.24594", "21809362"]}, {"Citation": "El-Shamy AI, Abdel-Razek AF, Nassar MI. 2015. Phytochemical review of Juncus L. genus (Fam. Juncaceae). Arab J Chem 8:614\u2013623. doi:10.1016/j.arabjc.2012.07.007.", "ArticleIdList": ["10.1016/j.arabjc.2012.07.007"]}, {"Citation": "Kov\u00e1cs A, Vasas A, Hohmann J. 2008. Natural phenanthrenes and their biological activity. Phytochemistry 69:1084\u20131110. doi:10.1016/j.phytochem.2007.12.005.", "ArticleIdList": ["10.1016/j.phytochem.2007.12.005", "18243254"]}, {"Citation": "Aquino R, Conti C, De Simone F, Orsi N, Pizza C, Stein ML. 1991. Antiviral activity of constituents of Tamus communis. J Chemother 3:305\u2013309. doi:10.1080/1120009X.1991.11739110.", "ArticleIdList": ["10.1080/1120009X.1991.11739110", "1667189"]}, {"Citation": "B\u00fas C, K\u00fasz N, Jakab G, Senobar Tahaei SA, Zupk\u00f3 I, Endr\u00e9sz V, Bogdanov A, Buri\u00e1n K, Csupor-L\u00f6ffler B, Hohmann J, Vasas A. 2018. Phenanthrenes from Juncus Compressus Jacq. with promising antiproliferative and anti-HSV-2 activities. Molecules 23:E2085. doi:10.3390/molecules23082085.", "ArticleIdList": ["10.3390/molecules23082085", "PMC6222307", "30127296"]}, {"Citation": "Behery FAA, Naeem ZEM, Maatooq GT, Amer MMA, Wen Z-H, Sheu J-H, Ahmed AF. 2007. Phenanthrenoids from Juncus acutus L., new natural lipopolysaccharide-inducible nitric oxide synthase inhibitors. Chem Pharm Bull 55:1264\u20131266. doi:10.1248/cpb.55.1264.", "ArticleIdList": ["10.1248/cpb.55.1264", "17666857"]}, {"Citation": "Della Greca M, Fiorentino A, Isidori M, Lavorgna M, Monaco P, Previtera L, Zarrelli A. 2002. Phenanthrenoids from the wetland Juncus acutus. Phytochemistry 60:633\u2013638. doi:10.1016/S0031-9422(02)00152-8.", "ArticleIdList": ["10.1016/S0031-9422(02)00152-8", "12126711"]}, {"Citation": "Wang Y-G, Wang Y-L, Zhai H-F, Liao Y-J, Zhang B, Huang J-M. 2012. Phenanthrenes from Juncus effusus with anxiolytic and sedative activities. Nat Prod Res 26:1234\u20131239. doi:10.1080/14786419.2011.561491.", "ArticleIdList": ["10.1080/14786419.2011.561491", "22017742"]}, {"Citation": "Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. 1994. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68:6147\u20136160.", "ArticleIdList": ["PMC237034", "8083956"]}, {"Citation": "Boulanger D, Waxweiler S, Karelle L, Loncar M, Mignon B, Dubuisson J, Thiry E, Pastoret PP. 1991. Characterization of monoclonal antibodies to bovine viral diarrhoea virus: evidence of a neutralizing activity against gp48 in the presence of goat anti-mouse immunoglobulin serum. J Gen Virol 72:1195\u20131198. doi:10.1099/0022-1317-72-5-1195.", "ArticleIdList": ["10.1099/0022-1317-72-5-1195", "1851819"]}, {"Citation": "Podevin P, Carpentier A, P\u00e8ne V, Aoudjehane L, Carri\u00e8re M, Za\u00efdi S, Hernandez C, Calle V, M\u00e9ritet J, Scatton O, Dreux M, Cosset F, Wakita T, Bartenschlager R, Demignot S, Conti F, Rosenberg AR, Calmus Y. 2010. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139:1355\u20131364. doi:10.1053/j.gastro.2010.06.058.", "ArticleIdList": ["10.1053/j.gastro.2010.06.058", "20600021"]}, {"Citation": "Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouill\u00e9 Y, Dubuisson J, Wakita T, Duverlie G, Wychowski C. 2007. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88:2495\u20132503. doi:10.1099/vir.0.82872-0.", "ArticleIdList": ["10.1099/vir.0.82872-0", "17698659"]}, {"Citation": "Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, Duverlie G, Ciczora Y, Wychowski C, Dubuisson J, Rouill\u00e9 Y. 2010. Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J Virol 84:773\u2013787. doi:10.1128/JVI.01190-09.", "ArticleIdList": ["10.1128/JVI.01190-09", "PMC2798365", "19906930"]}, {"Citation": "Li Y-P, Ramirez S, Jensen SB, Purcell RH, Gottwein JM, Bukh J. 2012. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc Natl Acad Sci U S A 109:19757\u201319762. doi:10.1073/pnas.1218260109.", "ArticleIdList": ["10.1073/pnas.1218260109", "PMC3511766", "23151512"]}, {"Citation": "Ramirez S, Mikkelsen LS, Gottwein JM, Bukh J. 2016. Robust HCV genotype 3a infectious cell culture system permits identification of escape variants with resistance to sofosbuvir. Gastroenterology 151:973\u2013985. doi:10.1053/j.gastro.2016.07.013.", "ArticleIdList": ["10.1053/j.gastro.2016.07.013", "27453546"]}, {"Citation": "P\u00e8ne V, Hernandez C, Vauloup-Fellous C, Garaud-Aunis J, Rosenberg AR. 2009. Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. J Viral Hepat 16:705\u2013715. doi:10.1111/j.1365-2893.2009.01118.x.", "ArticleIdList": ["10.1111/j.1365-2893.2009.01118.x", "19281487"]}, {"Citation": "Carri\u00e8re M, P\u00e8ne V, Breiman A, Conti F, Chouzenoux S, Meurs E, Andrieu M, Jaffray P, Grira L, Soubrane O, Sogni P, Calmus Y, Chaussade S, Rosenberg AR, Podevin P. 2007. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J Med Virol 79:155\u2013160. doi:10.1002/jmv.20773.", "ArticleIdList": ["10.1002/jmv.20773", "17177304"]}, {"Citation": "Lecot S, Belouzard S, Dubuisson J, Rouill\u00e9 Y. 2005. Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis. J Virol 79:10826\u201310829. doi:10.1128/JVI.79.16.10826-10829.2005.", "ArticleIdList": ["10.1128/JVI.79.16.10826-10829.2005", "PMC1182683", "16051874"]}, {"Citation": "Bartosch B, Dubuisson J, Cosset F-L. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197:633\u2013642. doi:10.1084/jem.20021756.", "ArticleIdList": ["10.1084/jem.20021756", "PMC2193821", "12615904"]}, {"Citation": "Rouill\u00e9 Y, Helle F, Delgrange D, Roingeard P, Voisset C, Blanchard E, Belouzard S, McKeating J, Patel AH, Maertens G, Wakita T, Wychowski C, Dubuisson J. 2006. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80:2832\u20132841. doi:10.1128/JVI.80.6.2832-2841.2006.", "ArticleIdList": ["10.1128/JVI.80.6.2832-2841.2006", "PMC1395453", "16501092"]}, {"Citation": "Castelain S, Descamps V, Thibault V, Fran\u00e7ois C, Bonte D, Morel V, Izopet J, Capron D, Zawadzki P, Duverlie G. 2004. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol 31:227\u2013234. doi:10.1016/j.jcv.2004.03.009.", "ArticleIdList": ["10.1016/j.jcv.2004.03.009", "15465417"]}, {"Citation": "Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, Mizokami M, Wakita T. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808\u20131817. doi:10.1053/j.gastro.2003.09.023.", "ArticleIdList": ["10.1053/j.gastro.2003.09.023", "14724833"]}, {"Citation": "Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE, Goff SP, Lindenbach BD, Rice CM. 2004. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J Virol 78:7400\u20137409. doi:10.1128/JVI.78.14.7400-7409.2004.", "ArticleIdList": ["10.1128/JVI.78.14.7400-7409.2004", "PMC434129", "15220413"]}]}], "History": [{"Year": "2018", "Month": "11", "Day": "9"}, {"Year": "2019", "Month": "2", "Day": "21"}, {"Year": "2019", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30842319", "PMC6498043", "10.1128/JVI.02009-18", "JVI.02009-18"]}}]}